{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:14:14Z","timestamp":1791980054991,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":61,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1124\/jpet.124.002258","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:35:17Z","timestamp":1726486517000},"page":"361-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sensory-Motor Neuropathy in Mfn2 T105M Knock-in Mice and Its Reversal by a Novel Piperine-Derived Mitofusin Activator"],"prefix":"10.1016","volume":"391","author":[{"given":"Jochen","family":"Weigele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8995-1624","authenticated-orcid":false,"suffix":"II","given":"Gerald W.","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.124.002258_bib1","article-title":"Assessing functional performance in the mdx mouse model","volume":"27","author":"Aartsma-Rus","year":"2014","journal-title":"JoVE"},{"key":"10.1124\/jpet.124.002258_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2017.08.002","article-title":"MicroRNAs Induce a Permissive Chromatin Environment that Enables Neuronal Subtype-Specific Reprogramming of Adult Human Fibroblasts","volume":"21","author":"Abernathy","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1124\/jpet.124.002258_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167573","article-title":"Mice Hemizygous for a Pathogenic Mitofusin-2 Allele Exhibit Hind Limb\/Foot Gait Deficits and Phenotypic Perturbations in Nerve and Muscle","volume":"11","author":"Bannerman","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/jpet.124.002258_bib4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00415-017-8474-3","article-title":"Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review","volume":"264","author":"Berciano","year":"2017","journal-title":"J Neurol"},{"key":"10.1124\/jpet.124.002258_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1124\/jpet.102.034728","article-title":"Piperine, a Major Constituent of Black Pepper, Inhibits Human P-Glycoprotein and CYP3A4","volume":"302","author":"Bhardwaj","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002258_bib6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamaneurol.2014.629","article-title":"Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features","volume":"71","author":"Bombelli","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1124\/jpet.124.002258_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddp326","article-title":"Mitochondrial dynamics\u2013fusion, fission, movement, and mitophagy\u2013in neurodegenerative diseases","volume":"18","author":"Chen","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.124.002258_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1749-6632.2010.05615.x","article-title":"Physiological functions of mitochondrial fusion","volume":"1201","author":"Chen","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.124.002258_bib9","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1007\/s11033-014-3663-y","article-title":"Mitochondrial dynamic changes in health and genetic diseases","volume":"41","author":"Chen","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1124\/jpet.124.002258_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.0306-5251.2001.01568.x","article-title":"Activated charcoal alone or after gastric lavage: a simulated large paracetamol intoxication","volume":"53","author":"Christophersen","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.124.002258_bib11","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/brain\/awl174","article-title":"Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations","volume":"129","author":"Chung","year":"2006","journal-title":"Brain"},{"key":"10.1124\/jpet.124.002258_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3959(93)90059-X","article-title":"Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain","volume":"53","author":"Courteix","year":"1993","journal-title":"Pain"},{"key":"10.1124\/jpet.124.002258_bib13","article-title":"Mitochondrial Phenotypes in Genetically Diverse Neurodegenerative Diseases and Their Response to Mitofusin Activation","volume":"11","author":"Dang","year":"2022","journal-title":"Cells 11"},{"key":"10.1124\/jpet.124.002258_bib14","doi-asserted-by":"crossref","first-page":"12506","DOI":"10.1021\/acs.jmedchem.1c00163","article-title":"Pharmacophore-Based Design of Phenyl-[hydroxycyclohexyl] Cycloalkyl-Carboxamide Mitofusin Activators with Improved Neuronal Activity","volume":"64","author":"Dang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.124.002258_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/hmg\/ddac287","article-title":"Activating mitofusins interrupts mitochondrial degeneration and delays disease progression in SOD1 mutant amyotrophic lateral sclerosis","volume":"32","author":"Dang","year":"2023","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.124.002258_bib16","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1021\/acs.jmedchem.0c00366","article-title":"Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases","volume":"63","author":"Dang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.124.002258_bib17","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1093\/hmg\/ddm226","article-title":"Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content","volume":"16","author":"De Vos","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.124.002258_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1083\/jcb.200611080","article-title":"Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations","volume":"176","author":"Detmer","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1124\/jpet.124.002258_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/hmg\/ddm314","article-title":"Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A","volume":"17","author":"Detmer","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.124.002258_bib20","unstructured":"Dorn II GW. (2023) inventor and assignee. Mitofusin activators having an endocyclic-bonded carbonyl group and methods of use thereof. United States patent US WO 2023 196340A1. Appl. No.: PCT\/US2023\/017479; published Oct 12, 2023."},{"key":"10.1124\/jpet.124.002258_bib21","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.4103\/1673-5374.310684","article-title":"Mitofusin activation enhances mitochondrial motility and promotes neuroregeneration in CMT2A","volume":"16","author":"Dorn","year":"2021","journal-title":"Neural Regen Res"},{"key":"10.1124\/jpet.124.002258_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-physiol-020518-114358","article-title":"Evolving Concepts of Mitochondrial Dynamics","volume":"81","author":"Dorn","year":"2019","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/jpet.124.002258_bib23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3389\/fphys.2020.00782","article-title":"Mitofusin 2 Dysfunction and Disease in Mice and Men","volume":"11","author":"Dorn","year":"2020","journal-title":"Front Physiol"},{"key":"10.1124\/jpet.124.002258_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yjmcc.2020.04.016","article-title":"Mitofusins as mitochondrial anchors and tethers","volume":"142","author":"Dorn","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.124.002258_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells11061049","article-title":"Predicting Mitochondrial Dynamic Behavior in Genetically Defined Neurodegenerative Diseases","volume":"11","author":"Dorn","year":"2022","journal-title":"Cells"},{"key":"10.1124\/jpet.124.002258_bib26","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/0006-2952(75)90450-5","article-title":"Enterohepatic circulation of indomethacin and its role in intestinal irritation","volume":"24","author":"Duggan","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.124.002258_bib27","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/WNL.0b013e31821a441e","article-title":"MFN2 mutations cause severe phenotypes in most patients with CMT2A","volume":"76","author":"Feely","year":"2011","journal-title":"Neurology"},{"key":"10.1124\/jpet.124.002258_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.61119","article-title":"Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A","volume":"9","author":"Franco","year":"2020","journal-title":"Elife"},{"key":"10.1124\/jpet.124.002258_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.122.001332","article-title":"Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A","volume":"383","author":"Franco","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002258_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature20156","article-title":"Correcting mitochondrial fusion by manipulating mitofusin conformations","volume":"540","author":"Franco","year":"2016","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002258_bib31","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84235","article-title":"A human mitofusin 2 mutation can cause mitophagic cardiomyopathy","volume":"12","author":"Franco","year":"2023","journal-title":"Elife"},{"key":"10.1124\/jpet.124.002258_bib32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp-2014-308826","article-title":"CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis","volume":"86","author":"Fridman","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1124\/jpet.124.002258_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/brain\/103.2.259","article-title":"The clinical features of hereditary motor and sensory neuropathy types I and II","volume":"103","author":"Harding","year":"1980","journal-title":"Brain"},{"key":"10.1124\/jpet.124.002258_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/joa.12707","article-title":"Anatomy and development of the extrahepatic biliary system in mouse and rat: a perspective on the evolutionary loss of the gallbladder","volume":"232","author":"Higashiyama","year":"2018","journal-title":"J Anat"},{"key":"10.1124\/jpet.124.002258_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.572182","article-title":"Role of Mitofusins and Mitophagy in Life or Death Decisions","volume":"8","author":"Joaquim","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1124\/jpet.124.002258_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrn2417","article-title":"Mitochondrial fragmentation in neurodegeneration","volume":"9","author":"Knott","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.124.002258_bib37","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/hmg\/ddz008","article-title":"MFN2 mutations in Charcot-Marie-Tooth disease alter mitochondria-associated ER membrane function but do not impair bioenergetics","volume":"28","author":"Larrea","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.124.002258_bib38","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1248\/cpb.53.832","article-title":"Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity","volume":"53","author":"Lee","year":"2005","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/jpet.124.002258_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115011","article-title":"Potential role of mitochondria-associated endoplasmic reticulum membrane proteins in diseases","volume":"199","author":"Mao","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.124.002258_bib40","doi-asserted-by":"crossref","DOI":"10.3791\/51212-v","article-title":"Measuring changes in tactile sensitivity in the hind paw of mice using an electronic von Frey apparatus","author":"Martinov","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1124\/jpet.124.002258_bib41","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3389\/fphar.2020.01153","article-title":"NSAID-Gut Microbiota Interactions","volume":"11","author":"Maseda","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.124.002258_bib42","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s13311-021-01099-2","article-title":"Axonal Charcot-Marie-Tooth Disease: from Common Pathogenic Mechanisms to Emerging Treatment Opportunities","volume":"18","author":"McCray","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.124.002258_bib43","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjp.0706040","article-title":"Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1)","volume":"144","author":"McNamara","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.124.002258_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/science.adh9351","article-title":"Splice variants of mitofusin 2 shape the endoplasmic reticulum and tether it to mitochondria","volume":"380","author":"Na\u00f3n","year":"2023","journal-title":"Science"},{"key":"10.1124\/jpet.124.002258_bib45","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.bbamcr.2014.05.011","article-title":"At the right distance: ER-mitochondria juxtaposition in cell life and death","volume":"1843","author":"Naon","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.124.002258_bib46","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1212\/01.wnl.0000311275.89032.22","article-title":"Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations","volume":"70","author":"Nicholson","year":"2008","journal-title":"Neurology"},{"key":"10.1124\/jpet.124.002258_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g459","article-title":"Chronic and slowly progressive weakness of the legs and hands","volume":"348","author":"Nightingale","year":"2014","journal-title":"BMJ"},{"key":"10.1124\/jpet.124.002258_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1208\/s12248-008-9079-7","article-title":"Predicting pharmacokinetics of drugs using physiologically based modeling\u2013application to food effects","volume":"11","author":"Parrott","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/jpet.124.002258_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nbd.2014.01.005","article-title":"Mice with a deletion of the major central myelin protein exhibit hypersensitivity to noxious thermal stimuli: involvement of central sensitization","volume":"65","author":"Petit","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.124.002258_bib50","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1093\/brain\/awaa323","article-title":"Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study","volume":"143","author":"Pipis","year":"2020","journal-title":"Brain"},{"key":"10.1124\/jpet.124.002258_bib51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0378-4274(83)90198-4","article-title":"Acute and subacute toxicity of piperine in mice, rats and hamsters","volume":"16","author":"Piyachaturawat","year":"1983","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.124.002258_bib52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.aao1785","article-title":"MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A","volume":"360","author":"Rocha","year":"2018","journal-title":"Science"},{"key":"10.1124\/jpet.124.002258_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn3156","article-title":"Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration","volume":"13","author":"Sheng","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.124.002258_bib54","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/CIRCRESAHA.116.306374","article-title":"How mitochondrial dynamism orchestrates mitophagy","volume":"116","author":"Shirihai","year":"2015","journal-title":"Circ Res"},{"key":"10.1124\/jpet.124.002258_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2015.05.033","article-title":"MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives","volume":"356","author":"Stuppia","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1124\/jpet.124.002258_bib56","series-title":"Pharmacology","first-page":"175","article-title":"Chapter 9 - Drug Excretion","author":"Taft","year":"2009"},{"key":"10.1124\/jpet.124.002258_bib57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1606","article-title":"Mitochondrial DNA mutations in human disease","volume":"6","author":"Taylor","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1124\/jpet.124.002258_bib58","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/brain\/awl126","article-title":"MFN2 mutation distribution and genotype\/phenotype correlation in Charcot-Marie-Tooth type 2","volume":"129","author":"Verhoeven","year":"2006","journal-title":"Brain"},{"key":"10.1124\/jpet.124.002258_bib59","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1038\/s41467-022-31324-1","article-title":"Modulating mitofusins to control mitochondrial function and signaling","volume":"13","author":"Zacharioudakis","year":"2022","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.124.002258_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.858286","article-title":"The Role of Impaired Mitochondrial Dynamics in MFN2-Mediated Pathology","volume":"10","author":"Zaman","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1124\/jpet.124.002258_bib61","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/chemistry4030047","article-title":"Piperine Derivatives Enhance Fusion and Axonal Transport of Mitochondria by Activating Mitofusins","volume":"4","author":"Zhang","year":"2022","journal-title":"Chemistry"},{"key":"10.1124\/jpet.124.002258_bib62","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.20797","article-title":"Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2","volume":"59","author":"Z\u00fcchner","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.124.002258_bib63","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ng1341","article-title":"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A","volume":"36","author":"Z\u00fcchner","year":"2004","journal-title":"Nat Genet"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524178123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524178123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.124.002258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T10:13:02Z","timestamp":1743243182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524178123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0022356524178123"],"URL":"https:\/\/doi.org\/10.1124\/jpet.124.002258","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sensory-Motor Neuropathy in Mfn2 T105M Knock-in Mice and Its Reversal by a Novel Piperine-Derived Mitofusin Activator","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.124.002258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}